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Abstract
Background: Sigma-1 receptors are involved in regulation of neuronal activities presumably
through regulation of the activity of ion channels. Sigma-1 receptors also play a role in growth and
metastasis of cancerous cells. Intracellular distribution of sigma-1 receptors have been linked to
sphingolipid-enriched domains.
Results: We report that in CHO-K1 cells sigma-1 receptors target to focal adhesion contacts
(FAC) where they colocalize with Talin and Kv1.4 potassium channels. The levels of sigma-1
receptors in the FAC were significantly increased by application of sigma-1 receptor ligands and by
filamentous actin (F-actin) polymerization with phalloidin. The total length of FAC (measured by
the focal adhesion marker, talin) was concomitantly increased in the presence of sigma-1 receptors
upon phalloidin treatment. Only sigma-1 receptor ligands, however, resulted in an increase of
sigma-1 receptors in the FAC, independent of talin. Additionally, a novel approach was utilized to
allow an assessment of the half life of endogenous sigma-1 receptors in CHO-K1 cells, which was
measured to be at least 72 hours.
Conclusion: Ligand activated sigma-1 receptors translocate into FAC from a pool of receptors
stored in ER lipid rafts presumably for inhibition of Kv1.4 channels. Stabilization of actin filaments
is likely to be important for targeting sigma-1 receptors to Focal Adhesion Contacts in CHO-K1
cells.
Background
Sigma-1 receptors have been shown to be expressed in
many tissues and enriched in the brain[1]. This receptor
was first described as a type of opioid receptor[2], but fur-
ther experiments showed that the sigma-1 receptor has
distinct pharmacological properties[3]. It binds to drugs
such as (+)-pentazocine[4], cocaine[5], methampheta-
mine[6]) and neurosteroids[7] and is implicated in cer-
tain forms of psychoses[8], pain tolerance[9], learning
and memory and attention deficit disorders[8]. Myriad
properties that are associated with sigma-1 receptors led
some to consider the receptors as intracellular amplifi-
ers[10]. Endogenous ligands are unknown at present and
common signal transduction pathways remain elusive.
However, electrophysiological experiments have shed
some light on a significant role of sigma-1 receptors
involving an inhibitory action on the activity of ion chan-
nels such as potassium Kv1.4, Kv1.5[11] and chloride
VRCC[12] channels. These data provided evidence for a
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possible general function of sigma-1 receptors in mainte-
nance of the excitability of cell membranes in response to
psychotomimetic drugs. Involvement of sigma-1 recep-
tors in a plethora of known pathways is implied in it's
gene promoter, which contains an AP-1 complex (regulat-
ing immediate early gene products) binding
sequence[13]. Inhibition of AP-1 expression through sup-
pression of the extracellular receptor kinase (ERK) MAPK
pathway activity resulted in significant downregulation of
the total level of sigma-1 receptors[14]. On the other
hand, activation of sigma-1 receptors resulted in upregu-
lation of the FRA-2 gene[15,16], a member of the AP-1
subfamily.
Sigma-1 receptors have been predicted to be transmem-
brane proteins[11]. They are localized to sphingosine-
enriched lipid rafts on the bundles of the endoplasmic
reticulum (ER) and have been shown to target to the
plasma membrane (PM) as well. Translocation of sigma-
1 receptors from the ER to the PM has been
reported[17,18]. In cultured oligodendrocytes sigma-1
receptors are involved in trafficking of galactosylceramide,
an important component of myelin[19].
Additionally, cancer cell lines have been shown to be sig-
nificantly enriched with sigma-1 receptors[20]. Applica-
tion of sigma-1 receptor drugs as well as silencing of
sigma-1 receptors with RNAi inhibited cell adhesion to
the plating surface and suggested novel functions of
sigma-1 receptors in metastasis[20].
Here we report for the first time that in Chinese hamster
ovary (CHO-K1) cells sigma-1 receptors target to focal
adhesion contacts (FAC) where they colocalize with Kv1.4
and talin. The appearance of sigma-1 receptors in the FAC
increased significantly upon treatment with the sigma-1
receptor ligands (+)-pentazocine, haloperidol and
iodoazidococaine[21,22] as well as by stabilization of fil-
amentous actin with phalloidin. We also utilized a novel
protocol for photolabeling endogenous sigma-1 receptors
in live cells, allowing us to determine a significant intrac-
ellular stability of the endogenous receptor pools in CHO-
K1 cells.
Results
The specificity of rabbit polyclonal antibody against the
purified whole-sequence sigma-1 receptor protein[23]
was confirmed by preadsorbtion with antigen (Fig. 1). The
sigma-1 receptor immunocytochemical staining revealed
that the receptors were localized to the nuclear envelope
(NE), endoplasmic reticulum (ER) and the focal adhesion
contacts (FAC). In order to detect sigma-1 receptors in the
FAC, it was critical, before fixation, to rinse the cells for a
short   time (30 sec) with DMEM (no serum present) or
DPBS with Ca2+ & Mg2+ present (Fig. 2.). These results
support the present literature data[17,18] indicating that
the sigma-1 receptors are able to alter their distribution
within the cell and further indicates that divalent cations
can modify this distribution, especially in the FAC.
To support the observation that the sigma-1 receptors are
present in true FAC a double stain for talin (a FAC marker)
was used to show a high level of colocalization (Fig. 3. A–
C). It has been previously demonstrated [11,24,25], that
sigma-1 receptors modulate the activity of Kv1.4 potas-
sium channels. We found that in CHO-K1 cells Kv1.4 is
also targeted to FAC under all sample preparation condi-
tions and double staining for Kv1.4 and sigma-1 receptors
showed colocalization in the FAC (Fig 3. D–F).
Further, we show that the sigma-1 receptors were found to
localize to the tips of F-Actin rods, where the FAC form
(Fig 3. G,H).
Intracellular protein-protein interactions of the sigma-1
receptors in a response to stimulation by specific ligands
such as (+)-pentazocine, SKF10047 or cocaine has been
demonstrated to change[18]. We therefore explored the
possibility that various sigma-1 receptor ligands could
alter the amount of receptor in FAC. In CHO-K1 cells fol-
lowing various treatment with (+)-pentazocine, iodoazi-
dococaine and phalloidin (which directly stabilizes F-
Actin) we observed that there was a significant increase of
the level of sigma-1 receptors in the FAC (Fig. 4.). The
level of talin in the FAC in a response to the various lig-
ands showed only a slight increase. Following direct actin
filament stabilization with phalloidin a doubling of the
level of talin in the FAC was observed, while the sigma-1
receptor levels in the FAC increased more than 6 fold (Fig.
4.).
Since the increase in sigma-1 receptors in FAC upon addi-
tion of sigma-1 receptor ligands occured in a relatively
Preadsorbtion control showing the specificity of the Anti- sigma-1 receptor antibody Figure 1
Preadsorbtion control showing the specificity of the 
Anti-sigma-1 receptor antibody. CHO-K1 cells stained 
with anti-sigma1 antibody (0.6 µg/ml). A – no preadsorbtion; 
B – before immunostaining antibody was preadsorbed for 1 h 
with the purified sigma-1 protein (25 µg/ml).Journal of Molecular Signaling 2007, 2:8 http://www.jmolecularsignaling.com/content/2/1/8
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short period of time (30 min), we hypothesized that this
relocation may be due to recruitment of receptors from
intracellular pools. In order to determine the availability
of the sigma-1 receptors for translocation, we assessed the
stability of the receptors in CHO-K1 cells. These experi-
ments were performed by using a unique intracellular
photolabeling approach with the high affinity sigma-1
receptor photoprobe, [125I]-IACoc, which forms a cova-
lent linkage with the receptor residues upon photoly-
sis[21,22]. Fig. 5 shows that in situ specific photolabeling
in live cells was successful in identifying the sigma-1
receptor. Application of this "pulse-chase" approach for
intact cell labeling therefore provided an opportunity to
address the question of intracellular stability of photola-
beled sigma-1 receptors thus demonstrating that a consid-
erable stable intracellular pool of sigma-1 receptors occurs
in CHO-K1 cells. Potential mechanisms of degradation or
turnover of the sigma-1 receptors using inhibitors of pro-
teosomal and lysosomal protein digestion were further
investigated. The results demonstrated that the half life of
the ligand-bound form of the sigma-1 receptor in CHO-
K1 cells is 72 hours and was insensitive to lysosomal
(chloroquine) and proteosomal (lactacystine) inhibitors.
Discussion
The data reported in this paper show a profound diversity
in sigma-1 receptor distribution in CHO-K1 cells. Sigma-
1 receptors have previously been shown to localize to the
plasma membrane[11,20,26]. In contrast to other cell
types[17,18,20,26] sigma-1 receptors are localized to
focal adhesions in CHO-K1 cells in a sigma-1 receptor lig-
and dependent and F-actin stabilizing manner.
Interestingly, a 30 sec rinsing condition (before fixation)
with DPBS with divalent cations present appeared to be a
critical factor for retaining the sigma-1 receptors in the
FAC. When the cells were rinsed with DMEM (without
serum), instead of DPBS, the appearance of the sigma-1
receptors was also preserved in FAC, leading to the conclu-
sion that the presence of divalent cations stabilized the
sigma-1 receptors in the FAC, but did not appear to stim-
ulate translocation of the sigma-1 receptors to the FAC.
One established function of sigma-1 receptors is modula-
tion of the activity of Kv1.4 potassium channels, presum-
ably as regulatory inhibitory subunits of these
channels[11]. Under the experimental conditions
reported in this paper the Kv1.4 potassium channels were
confined to FAC. The sigma-1 receptor distributed to FAC,
on the other hand, indicating a clear regulation by sigma-
1 receptor ligands. Although the state of localization of
Kv1.4 potassium channels was not assessed with regard to
the sigma-1 receptor ligands in this study, it is reasonable
to propose that increased focal adhesion targeting of the
sigma-1 receptors is a regulatory mechanism for modula-
tion of Kv1.4 voltage-gated channels in FAC in CHO-K1
cells. Volume-regulated chloride channels (VRCC) have
also been reported to be profoundly inhibited by sigma-1
receptor ligands in various tumor cells[12]. Although little
has been reported in the literature regarding the presence
of ion channels in focal adhesions, a recent report is con-
sistent with the presence of HERG potassium channels in
the FACs[27].
In CHO-K1 cells during a 30 sec rinsing with buffers with or w/o Ca2+ and Mg2+ before fixation changed the intracellular distri- bution of endogenous sigma-1 receptors Figure 2
In CHO-K1 cells during a 30 sec rinsing with buffers with or w/o Ca2+ and Mg2+ before fixation changed the 
intracellular distribution of endogenous sigma-1 receptors. A. Cells were rinsed with DPBS w/o Ca2+ and Mg2+ and 
DMEM. B. Cells were rinsed with DPBS with different concentrations of Ca2+ and Mg2+Journal of Molecular Signaling 2007, 2:8 http://www.jmolecularsignaling.com/content/2/1/8
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Previous investigations have shown that in NG-108 cells
treated with (+)-pentazocine, sigma-1 receptors translo-
cated to the plasma membrane[18]. Our data further
demonstrate that in CHO-K1 cells, the sigma-1 receptors
target to the FAC via a specific drug response without a
concomitant increase in the total focal adhesion contacts,
as measured by the marker protein for FAC, talin (Fig. 3).
Sigma-1 receptor ligands such as (+)-pentazocine[18],
haloperidol and iodoazidococaine[28], may result in con-
formational changes in the receptor, leading to recruit-
ment of the receptor to FAC via translocation pathways. It
is also possible that multiple intracellular or extracellular
signal transduction pathways are triggered by sigma-1
receptor ligands that indirectly result in FAC translocation
of the sigma-1 receptors.
Interestingly, stabilization of F-Actin by phalloidin led to
an increase in the level of talin and sigma-1 receptors
together in FAC. Actin morphology remained intact after
the sigma-1 receptor ligand treatments, whereas after
phalloidin application, strong extended F-actin stress fib-
ers formed (Fig. 3. H) with sigma-1 receptors localized to
the tips of the strong fibers. The increase of sigma-1 recep-
tors in FAC induced by the irreversible phalloidin F-actin
polymerization indicated that the sigma-1 receptors are
stabilized in FAC by F-actin polymerization.
FAC have been shown to interact in signaling pathways
with lipid raft proteins, although it's not clear how lipid
rafts commute between ER bundles and plasma mem-
brane rafts[29]. Lisanti and coworkers showed that caveo-
lin-1 and caveolin-2 proteins, which are enriched in lipid
rafts in a phosphorylated form, localized to FAC, whereas
unphosphorylated caveolins localized to the ER[29]. Pre-
viously it had been shown by Hayshi and Su that sigma-1
receptors associated with caveolin-2 in ER lipid rafts[30].
The mechanism by which the rate and direction of these
processes are integrated with the cytosolic transport
machinery remains obscure. There is also no clear evi-
dence for how lipid droplets may be mobilized via actin
filaments. In this regard there may well be an intimate
relationship between lipid rafts and sigma-1 receptors
regarding translocation to the barbed ends of actin fila-
ments. Fluorescence recovery after photobleaching
(FRAP) experiments performed in the Su laboratory sug-
gested that the transfected GFP-sigma-1 receptors were
Endogenous Sigma-1 receptors colocalize with other pro- teins in the FAC Figure 3
Endogenous Sigma-1 receptors colocalize with other 
proteins in the FAC. A-C. Colocalization with talin. A-
sigma-1; B-talin; C-Overlay. D-F. Colocalization with Kv1.4. 
potassium channel. D-sigma-1; E-Kv1.4.; F-Overlay. G, H. 
Colocalization of sigma-1(green) and F-Actin(red) in mock or 
phalloidin (50 ng/ml for 30 min) treated cells. Note, that the 
sigma-1 localized on the the barbed ends of actin filaments.
Dynamics of endogenous Sigma-1 receptor and Talin  appearence in the FAC in CHO-K1 cells under various treat- ment conditions Figure 4
Dynamics of endogenous Sigma-1 receptor and Talin 
appearence in the FAC in CHO-K1 cells under vari-
ous treatment conditions. All the compounds indicated 
were added to cells in complete 10% FBS supplemented 
DMEM for 30 min at a concentration of 10 µM except phal-
loidin (50 nM). Morphometrical quantitation of the amount 
of the sigma-1 receptor or talin in the FAC was performed 
with the Axiovision 4.3 software. The total amount of stain-
ing (in pixels) for each channel was quantitated for each 
image and divided by the number of cells (detected by DAPI 
staining of nuclei). 101–155 cells were measured per each 
condition.Journal of Molecular Signaling 2007, 2:8 http://www.jmolecularsignaling.com/content/2/1/8
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able to translocate quickly throughout the entire network
via the membranes of the ER[26].
The intracellular in situ sigma-1 receptor stability assessed
by [125I]-IACoc photolabeling (Fig. 5.) is consistent with
the possibility that recruitment of the sigma-1 receptors to
FAC from intracellular pools occurs. In this regard it is fur-
ther relevant that IACoc also increased appearance of the
sigma-1 receptors in the FAC (Fig. 4.).
Further studies are necessary to establish the role and the
level of sigma-1 receptor involvement in lipid rafts and
determine the direct sigma-1 receptor/lipid raft trafficking
pathway into the FAC and the plasma membrane.
Methods
Immunocytochemistry
Coverslips (Fisher #12-545-82) were precleaned over-
night in Aqua Regia, rinsed three times with double dis-
tilled H2O and stored in 100% ethanol. On the day of
seeding, coverslips were placed into each well of a 24 well
cell culture cluster (Costar #3524), dried and coated w
0.01% poly-L-ornithine (Sigma #5666) for 30 min, rinsed
three times with double distilled H2O for10 min each
time, aspirated and dried under UV illumination.
CHO-K1 cells were split in the amount of 1,000 cells/cov-
erslip and grown (in a 37°C incubator with 5% CO2) for
72 h in DMEM supplemented with 10% (vol/vol) of cos-
mic calf serum (HyClone #SH30087-03) and a 1× non-
essential aminoacid solution (Sigma #M7145) to reach a
well-spread morphology and confluence of 70–80%.
Cells were briefly rinsed twice for 30 sec with 1× DPBS
Stability of the sigma-1 receptors in CHO-K1 cells Figure 5
Stability of the sigma-1 receptors in CHO-K1 cells. Endogenous sigma-1 receptors were [125I]-IACoc photolabeled in 
live CHO-K1 cells by a brief photolysis (see Materials and Methods for details). Labeled cells were washed free of excess ligand 
and plated on culture dishes for various periods of time with or without inhibitors of proteolysis. A. Specificity of I125-azidoco-
caine labeling in live cells was tested by preincubation of cells with 5 µM haloperidol (hal), prior to [125I]-IACoc labeling (plus 
conditions). B. Autoradiogram of CHO-K1 cell lysate collected at different time points after plating of photolabeled cells: time 
0 – (lane # 1); after 24 h – (lanes # 2,3,4); after 48 h – (lanes # 5,6,7); after 72 h – (lanes # 8,9,10). The proteosomal inhibitor, 
lactacystine, 2 µM (lanes #3,6,9) was added; the lysosomal inhibitor, chloroquine, 100 nM (lanes # 4,7,10) was added. C. Quan-
tified data from the situ photolabeled sigma-1 receptor time-course from 3 independent experiments are represented in part 
B. These data indicate that in CHO-K1 cells the turnover of the ligand occupied sigma-1 receptor is slow with a half-life at least 
72 hours.Journal of Molecular Signaling 2007, 2:8 http://www.jmolecularsignaling.com/content/2/1/8
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with or where indicated without CaCl2 and MgCl2 (100
µg/ml) and fixed with sterile-filtered 3.7% paraformalde-
hyde, 0.02% picric acid 1× DPBS, pH 7.4 for 15 min. After
fixation, cells were rinsed three times with 1× PBS,
quenched with 100 mM glycine 1× PBS for 3 min, rinsed
three times with 1× PBS (each rinsing step was 3 min) and
permeabilized with 0.1% Triton X-100 for 3 min. Block-
ing reagent (10% normal goat serum, Biomeda # ES1028)
with 0.1% Triton X-100 present was used for 15 min.
Incubation time with the primary antibody was for 1 h,
and the cells were then rinsed three times with 1× PBS,
0.1% Triton X-100 and the secondary fluorophore conju-
gated goat-anti-rabbit/anti-mouse Fab (Molecular Probes
# A11070 was used for Alexa 488 anti-rabbit or A11020
for Alexa594 anti-mouse conjugates). The solution was
applied for 1 h (always in the presence of 2.5 µg/ml, 1×
PBS, 0.1% Triton X-100). The cells were then rinsed three
times with 1× PBS, 0.1% Triton, twice with PBS only,
stained with 300 nM DAPI for two min, rinsed three times
with PBS one min each time, aspirated and embedded
into Mowiol mounting media in the presence of 2%
Dabco, 2.5% Propyl Gallate and then fixed to the glass
slide using clear nail polish (Electron Microscopy Sciences
# 72180).
Images were taken under a Zeiss Axiovert 200 M epifluo-
rescent microscope at 100× oil objective with Axiovision
4.3 Software. Morphometrical quantitation of the lengths
of sigma-1 receptor and/or talin in the FAC was performed
with the same software. The total amount of staining (in
pixels) for each channel was measured for every image
and divided by the amount of cells (determined by
nuclear staining with DAPI). Phalloidin was from Molec-
ular Probes (# A12381). Monoclonal antibodies against
talin and Kv1.4 were from Sigma-Aldrich (#T3287 and
K1264, respectively). The anti-sigma-1 receptor polyclo-
nal antibody was prepared as described previously[23].
Photolabeling in situ by [125I]-Iodoazidococaine in intact 
CHO-K1 cells
Synthesis of [125I]-Iodoazidicocaine was performed as
described previously[21,22]. CHO-K1 cells were grown
on two 10 cm Petri Dishes to 80% confluence. Cells were
rinsed trice with DMEM (no serum) and 5 µM Haloperi-
dol (as a protector) was added to one dish for 20 min.
Then, the medium from the dishes was aspirated and 1
nM [125I]-Iodoazidicocaine was added into each dish in 1
ml of Dulbecco modified Eagles medium (DMEM) for 20
min. The cells were then rinsed three times with DMEM
(30 sec each time) and once with DPBS, aspirated and
dishes were exposed to an AH-6 mercury lamp for 5 sec at
a distance of ~15 cm.
Cells were then rinsed three times with DPBS, aspirated,
and 1 ml of Laemmli buffer 1× was added into each dish
and incubated on ice for 20 min. Lysate was passed
through a syringe with a 21 G needle (to shear DNA) and
collected. 80 µl were loaded into each well for SDS-PAGE
analysis.
To assess the stability of the photolabeled sigma-1 recep-
tor, CHO-K1 cells were grown to 80% confluence on one
15 cm Petri Dish and photolabeled as described above.
After exposure to light, cells were rinsed three times with
DPBS (30 sec each time), briefly detached by addition of
0.05 Trypsine-EDTA, collected by a quick low spin and
resuspended. Equal amounts of cells were split into 9 of 5
cm Petri Dishes in DMEM supplemented with 0.5% FBS.
An additional aliquot (time zero sample) was collected by
a brief centrifugation, the supernatant discarded and 350
µl of 1× Laemmli buffer was added to cells. An inhibitor
of proteosomal degradation (Lactacystine 2 µM) and an
inhibitor of lyzosomal degradation (Chloroquine 100
nM) were added to assess potential degradation pathways.
For harvesting, the medium was removed from the dishes
and 350 µl of 1× Laemmli buffer was added per dish, incu-
bated for 20 min on ice, passed through a syringe with a
21 G needle and collected for loading onto the SDS gel. 80
µl of sample was loaded per well.
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